Skip to search.
 TSX Down 1.14% TSX Ventures Down 1.33%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
0.27 Down 0.03(9.80%) 3:59PM EDT
Prev Close:0.30
Open:0.31
Bid:0.28 x 100
Ask:0.30 x 900
1y Target Est:2.33
Beta:3.24954
Next Earnings Date:10-May-16CYTX Earnings announcement
Day's Range:0.27 - 0.31
52wk Range:0.13 - 0.85
Volume:3,037,096
Avg Vol (3m):1,891,630
Market Cap:53.49M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTXDown 9.80%53.49M
BAXDown 0.72%24.42B
OSIRDown 7.30%183.63M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.12
Quarterly EPS Est (Mar-16) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback